SFWA
WINT

Summit Financial Wealth Advisors’s Windtree Therapeutics Inc WINT Stock Holding History

Summit Financial Wealth Advisors’s Portfolio WINT Stock Details WINT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-13,000
Closed -$15K – 152
2017
Q1 		$15K Hold
13,000
– – 0.01% 139
2016
Q4 		$16K Hold
13,000
– – 0.01% 139
2016
Q3 		$33K Buy
+13,000
New +$28.3K 0.01% 147

Other funds holding WINT

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

Summit Financial Wealth Advisors's WINT Position: Q2 2017 in Review

Summit Financial Wealth Advisors sold out of Windtree Therapeutics Inc (WINT) in Q2 2017, closing a stake of 13,000 shares — an estimated $15K sold.

Summit Financial Wealth Advisors first reported a position in WINT in Q3 2016 and held it in 3 quarters. The position peaked at $33K in Q3 2016. 3 funds tracked by Wall St. Rank hold WINT as of Q2 2017.

  • Summit Financial Wealth Advisors reported no remaining Windtree Therapeutics Inc position as of Q2 2017 after selling out during the quarter.
  • Summit Financial Wealth Advisors sold 13,000 Windtree Therapeutics Inc shares in Q2 2017, an estimated $15K.
  • Summit Financial Wealth Advisors first reported a position in Windtree Therapeutics Inc in Q3 2016 and held it in 3 quarters.
  • Summit Financial Wealth Advisors's Windtree Therapeutics Inc position peaked at $33K in Q3 2016.
  • 3 funds tracked by Wall St. Rank held Windtree Therapeutics Inc as of Q2 2017.

Based on Summit Financial Wealth Advisors's 13F filing for Q2 2017, filed 14 Aug 2017.